---
title: "Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298643183.md"
description: "Regeneron Pharmaceuticals (REGN) shares fell 1.78% to $793.26, marking a fifth consecutive day of losses and closing 7.69% below its 52-week high. Despite the decline, REGN outperformed competitors like Amgen and Gilead Sciences on a grim trading day where the S&P 500 and Dow Jones also dropped. Trading volume remained significantly below the 50-day average."
datetime: "2026-09-10T20:42:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298643183.md)
  - [en](https://longbridge.com/en/news/298643183.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298643183.md)
generator: "portal-rs"
---

# Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) shed 1.78% to $793.26 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.58% to 7,591.70 and Dow Jones Industrial Average falling 0.60% to 52,064.10.

This was the stock's fifth consecutive day of losses.

Regeneron Pharmaceuticals Inc. closed 7.69% below its 52-week high of $859.34, which the company reached on September 3rd.

The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. (AMGN) fell 2.25% to $382.47, Moderna Inc. (MRNA) rose 0.74% to $136.62, and Gilead Sciences Inc. (GILD) fell 0.58% to $144.81.

Trading volume (519,314) remained 230,399 below its 50-day average volume of 749,713.

Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

09-10-26 1642ET

### Related Stocks

- [REGN.US](https://longbridge.com/en/quote/REGN.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)

## Related News & Research

- [B. Metzler seel. Sohn & Co. AG Grows Stock Position in Regeneron Pharmaceuticals, Inc. $REGN](https://longbridge.com/en/news/298098855.md)
- [10:07 ETREGN Investor Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Notice - Contact SueWallSt](https://longbridge.com/en/news/297926980.md)
- [McDonald's Stock (MCD) Looks Tastier as It Gets Set For Another Value Meals Revamp](https://longbridge.com/en/news/299444824.md)
- [What's Going On With Sandisk Stock Friday?](https://longbridge.com/en/news/299469153.md)
- [Intel (INTC) Stock Looks Above Fair Value After Its 256% Run](https://longbridge.com/en/news/299431661.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**